Week 7 HW: Genettic Circuits: Part II

Assignment Part 1: Intracellular Artificial Neural Networks (IANNs)

1. What advantages do IANNs have over traditional genetic circuits?

In my research, I found that IANNs offer a much more flexible way to handle biological data compared to standard Boolean (ON/OFF) circuits. Here are the main benefits:

  • Graded vs. Binary Responses: While Boolean gates force a sharp decision, IANNs treat molecules as continuous inputs. This allows the cell to compute a proportional response (like partial induction) rather than just being fully “on” or “off.”
  • Multivariate Integration: IANNs can sum up multiple weighted inputs at once. This lets them perform pattern recognition and complex classification that simple logic gates can’t handle.
  • Noise & Fault Tolerance: IANNs are much more robust. In a Boolean gate, a single signal crossing a threshold can flip the whole output (brittleness). In an IANN, since it’s an analog sum, noise in one specific regulator has a limited effect on the final result.
  • Adaptability: The “weights” and thresholds of these networks can be tuned or trained through directed evolution, making them easier to optimize than rigid digital circuits.

2. Application: Sentinel Implant Probiotic

I propose using an IANN to create a “Guardian” probiotic (using Lactobacillus reuteri) designed to prevent infections around dental implants.

  • Input Behavior: The bacteria would monitor two specific analog cues:
    1. AHL concentration (pathogen quorum-sensing molecules).
    2. Local pH levels (which drop when acid-producing pathogens are present).
  • Output Behavior: These inputs are weighted within the cell. If the weighted sum of “AHL + Low pH” hits a certain threshold, the probiotic expresses an antimicrobial peptide at a proportional level.
  • The Goal: This creates a “soft AND” gate, ensuring the antimicrobial is only produced during actual dysbiosis, which protects the healthy oral flora.
  • Limitations: Setting precise biological weights is difficult. We also have to worry about signal leakage (AHL diffusing away) and the long-term stability of the engineered strain in a competitive biofilm.

3. Multilayer Perceptron Diagram

Below is a conceptual layout for a two-layer IANN:

Multilayer IANN Diagram Multilayer IANN Diagram
  • Layer 1: Takes inputs $X_1$ and $X_2$ (DNA-encoded regulators) and a bias. Their weighted sum drives the production of an endoribonuclease (ERN-A).
  • Layer 2: Uses the ERN-A from Layer 1 as a negative weight (it cleaves the mRNA of the output) and integrates it with a third input, $X_3$.
  • Output: The final fluorescent protein reflects a cascaded computation, allowing for a more complex “decision boundary” than a single-layer model.

Assignment Part 2: Fungal Materials

1. Existing Fungal Materials: Use Cases, Pros, and Cons

Fungi provide a versatile range of materials that can replace traditional plastics and leathers.

MaterialUse CaseAdvantagesDisadvantages
Mycelium Composites (MBCs)Packaging foam, insulation, acoustic panels.Low carbon footprint, fully compostable, fire-resistant.Low mechanical strength; absorbs water/moisture.
Myco-leatherSustainable fashion (e.g., Mylo™).50% lower $CO_2$ footprint than animal leather; high toughness.High production consistency is hard to maintain.
Fungal ChitosanMedical wound dressings.Biocompatible, biodegradable, and shellfish-allergen free.Requires strict regulatory approval; high cost at small scales.

2. Genetic Engineering in Fungi

What I would engineer: I’d want to engineer filamentous fungi (like Aspergillus) to secrete human growth factors (e.g., BMP-2) for bone and dental tissue regeneration.

Why Fungi over Bacteria?

  • Eukaryotic Processing: Fungi have the Golgi and ER needed to perform post-translational modifications (like glycosylation and disulfide bonding). Bacteria like E. coli often fail at this, leaving proteins unfolded or inactive.
  • High Secretion Capacity: Industrial fungi are powerhouses; they can secrete up to 100 g/L of protein, which is far beyond what most bacterial systems can do.
  • Safety: Fungi don’t produce endotoxins, making the purification process for medical-grade human proteins much simpler and safer.

Final Project: DNA Design & Backbone Documentation

Project Design Overview Project Design Overview Vector Map Selection Vector Map Selection


Backbone Vector Details

The insert sequence will be synthesized and cloned into the pET28a expression vector, obtained from Addgene.

Key Features of pET28a:

  • Promoter: Carries a T7 promoter for high-level, IPTG-inducible expression.
  • Selection Marker: Includes a kanamycin resistance cassette for reliable bacterial selection.
  • Purification Tag: Features an N-terminal His-tag, allowing for efficient protein purification via IMAC (Immobilized Metal Affinity Chromatography).

Experimental Context:

This backbone is widely validated for recombinant protein production in E. coli BL21(DE3) and is directly compatible with the final project’s experimental aim. By using this standardized vector, I ensure that the synthesized DNA can be expressed and verified using established laboratory protocols.


Progress Checklist for March 20 Deadline:

  • Draft Aim 1 and Project Summary.
  • Select HTGAA Industry Council members.
  • Shared Benchling/Kernel folder created.
  • Insert sequence designed and uploaded to shared folder.
  • Backbone vector documented (above).